Form 4 for IART INTEGRA LIFESCIENCES HOLDINGS CORP
Accepted 2024-08-20 00:00:00 ET · period of report 2024-08-19 · accession 0000917520-24-000095 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-08-20 | 2024-08-19 | IART | Mosebrook Jeffrey | SVP, Fin, Princ Acct Off | S - Sale | $21.58 | -1,191 | 36.1K | -3% | -$25.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-08-19 | S | D | 1,191 | $21.58 | 36,088 | D | — | — | (F1) The price shown above represents the weighted average price of the shares sold. The range of the sale prices was $21.575 to $21.58. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. |